By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immunomic Therapeutics 

313 W. Liberty Street
Suite 343
Lancaster  Pennsylvania  17603  U.S.A.
Phone: 717-327-1919 Fax: n/a



Company News
Immunomic Therapeutics Awarded SBIR Grant From NIH For Nanoplasmid Peanut Allergy Vaccine Development 3/31/2015 11:01:31 AM
Immunomic Therapeutics Receives Positive Feedback From FDA Following Pre-IND Discussions for Its Proprietary Peanut Allergy Vaccine 3/25/2015 11:09:25 AM
Immunomic Therapeutics To Present At BIO-Europe Annual Conference 3/9/2015 8:06:57 AM
Immunomic Therapeutics Explains Proprietary LAMP-vax Platform In Nature Advertorial Supplement 3/4/2015 7:23:34 AM
Immunomic Therapeutics To Present Data On Its Proprietary LAMP Vaccine Platform At 2015 American Academy of Allergy, Asthma and Immunology (AAAAI) Meeting 2/20/2015 8:50:38 AM
Astellas Pharma Inc. (ALPMY). Immunomic Therapeutics Forge $70 Million Vaccine Pact 1/30/2015 6:28:48 AM
Immunomic Therapeutics Closes $3 Million Debt Pre-Series B Round 7/17/2013 10:17:16 AM
Myriad Genetics, Inc. (MYGN) Supreme Court Case Has Promising Outcome for Immunomic Therapeutics 6/20/2013 9:47:45 AM
Immunomic Therapeutics Announces Interim Data Analysis of Phase I Study to Treat Japanese Red Cedar Allergy 4/25/2013 10:36:09 AM
Immunomic Therapeutics Begins Phase I Japanese Red Cedar JRC-LAMP-Vax Vaccine Safety Study 11/8/2012 12:43:40 PM